Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
Molecular Therapy. Nucleic Acids|March 14, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic reviewMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.Cancers|June 24, 2022
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) CellsCaterina Riillo, Daniele Caracciolo, Katia Grillone, et al.Tumori|March 11, 2011
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.Journal for Immunotherapy of Cancer|June 20, 2020
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockadePierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.Frontiers in Oncology|November 30, 2019
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-UpMichele Caraglia, Pierpaolo Correale, Rocco Giannicola, et al.Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.Critical Reviews in Oncology/Hematology|December 13, 2021
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific SocietiesAntonio Russo, Lorena Incorvaia, Ettore Capoluongo, et al.Journal of Hematology & Oncology|June 26, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation studyPierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, et al.Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.The Journal of Liquid Biopsy|January 19, 2026
Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societiesValerio Gristina, Umberto Malapelle, Gennaro Daniele, et al.Pageof 20